With more targets, more investment and more oppportunity than ever, vaccine technology is among the most dynamic in biomedicine today. Advances in reverse vaccinology, computer-aided biotechnology and disposable technologies are revolutionising R&D for infectious disease, paediatric and cancer therapies. Allied with new developments in formualtion, informatics and process development, the market will see growth of over 300% between 2009 and 2023.
Event Website : Vaccine Technology 2009 Conference

Location:	BSG House, London, UK
Contact:	Peter Barfoot peter.barfoot@bioportfolio.com 01300 321501
copy this event into your personal desktop calendar